Renaissance Capital logo

DYN News

US IPO Weekly Recap: Snowflake's IPO breaks records in a diverse 15 IPO week

SNOW

In the busiest week yet for the 2020 IPO market, 15 IPOs raised $8.7 billion. Snowflake (SNOW) took the spotlight, completing the largest software IPO ever and bagging the biggest billion-dollar pop in two decades. Eight SPACs joined the...read more

Preclinical rare disease biotech Dyne Therapeutics prices upsized IPO at $19, above the range

Dyne Therapeutics logo

Dyne Therapeutics, a preclinical biotech developing oligonucleotide therapies for rare muscular diseases, raised $233 million by offering 12.3 million shares at $19, above the range of $16 to $18. The company offered 2.0 million more shares than anticipated. At...read more

US IPO Week Ahead: The IPO market braces for a September SNOWstorm in a 14 IPO week

SNOW

Updated Monday, 9/14. The post-Labor Day IPO frenzy is here as 14 IPOs plan to raise $7.8 billion in the coming week, led by cloud data unicorn Snowflake (SNOW). It is expected to be the biggest week for the IPO market by...read more

Preclinical rare disease biotech Dyne Therapeutics sets terms for $175 million IPO

Dyne Therapeutics logo

Dyne Therapeutics, a preclinical biotech developing oligonucleotide therapies for rare muscular diseases, announced terms for its IPO on Thursday. The Waltham, MA-based company plans to raise $175 million by offering 10.3 million shares at a price range of...read more